Taipei, Taiwan

Cheng-Han Tsai

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Taoyuan, TW (2013 - 2018)
  • Taipei, TW (2013 - 2023)
  • Newark, DE (US) (2023)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Cheng-Han Tsai in Biomedical Technologies**

Introduction

Cheng-Han Tsai, an accomplished inventor based in Taipei, Taiwan, has made significant contributions to the field of biomedical technologies through his innovative patents. With a total of 15 patents to his name, he is recognized for his driven approach towards developing solutions for complex medical conditions.

Latest Patents

Among his latest patents, Cheng-Han Tsai has focused on microbioreactors and their applications in biomedical research. Notably, he has developed matrix metalloproteinase (MMP) inhibitors, specifically hydantoin-based compounds that target macrophage elastase (MMP-12). These compounds are significant in treating various diseases mediated by MMP-12, including asthma, chronic obstructive pulmonary disease (COPD), and even cancer. His work lays the foundation for new treatment methodologies for numerous conditions, such as idiopathic pulmonary fibrosis (IPF), arthritis, and chronic kidney diseases.

Career Highlights

Cheng-Han Tsai’s career has seen him associated with renowned companies such as Hewlett-Packard Development Company L.P. and Lite-On Technology Corporation. His experiences in these leading technology firms have contributed to his expertise in developing innovative biomedical solutions and enhancing product functionalities.

Collaborations

Throughout his career, Cheng-Han has collaborated with esteemed colleagues including Chia-Ming Tsai and Wenjin Yang. These collaborations have led to a fruitful exchange of ideas and knowledge, furthering advancements in their shared fields of interest.

Conclusion

Cheng-Han Tsai’s work exemplifies the spirit of innovation in addressing critical biomedical challenges. His contributions, especially through his latest patents, are set to make significant impacts in various healthcare sectors, showcasing the importance of inventive minds in the ongoing quest for improved medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…